No one here mentioned the following assertion that Mc made during the Bloom Burton presentation:
He said (paraphrasing) that Titan and Intuitive currently have all of the IP for single port robotic surgery locked up, effectively preventing other entrants into this space.
This is good for two reasons. First, Titan stands to benefit by licensing the IP in its portfolio. Secondly, this will make Titan an attractive acquisition target for Intuitive eventually.
Market Data 
Markets 
AI
